Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-A13632-50 50 µg (1 mg/ml) $460 
ACE2 / ACE-2 Antibody - Human Testis: Formalin-Fixed, Paraffin-Embedded (FFPE)
ACE2 / ACE-2 Antibody - Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)
ACE2 / ACE-2 Antibody - Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)
ACE2 / ACE-2 Antibody - Western Blot: LS-A13632 (1:100) vs. full-length recombinant human ACE2 protein. Lane 7: 50 ng, Lane 8: 100 ng, Lane 9 500ng. Detection fluorescent conjugated anti-rabbit secondary antibody (1:100).
ACE2 / ACE-2 Antibody - Indirect detection ELISA against full length Recombinant Human ACE2. Primary antibody LS-13632 was diluted 1:100 (10ug/mL final concentration). Secondary goat anti-rabbit HRP conjugated antibody was diluted 1:100.
ACE2 / ACE-2 Antibody - Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control).  Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Electropherogram)
ACE2 / ACE-2 Antibody - Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control).  Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Virtual Blot)
ACE2 / ACE-2 Antibody - Human Testis: Formalin-Fixed, Paraffin-Embedded (FFPE)
ACE2 / ACE-2 Antibody - Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)
ACE2 / ACE-2 Antibody - Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)
ACE2 / ACE-2 Antibody - Western Blot: LS-A13632 (1:100) vs. full-length recombinant human ACE2 protein. Lane 7: 50 ng, Lane 8: 100 ng, Lane 9 500ng. Detection fluorescent conjugated anti-rabbit secondary antibody (1:100).
ACE2 / ACE-2 Antibody - Indirect detection ELISA against full length Recombinant Human ACE2. Primary antibody LS-13632 was diluted 1:100 (10ug/mL final concentration). Secondary goat anti-rabbit HRP conjugated antibody was diluted 1:100.
ACE2 / ACE-2 Antibody - Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control).  Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Electropherogram)
ACE2 / ACE-2 Antibody - Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control).  Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Virtual Blot)
1 of 7
2 of 7
3 of 7
4 of 7
5 of 7
6 of 7
7 of 7

PathPlus™ Polyclonal Rabbit anti‑Human ACE2 / ACE‑2 Antibody (IHC) LS‑A13632

PathPlus™ Polyclonal Rabbit anti‑Human ACE2 / ACE‑2 Antibody (IHC) LS‑A13632

Antibody:
ACE2 / ACE-2 Rabbit anti-Human Polyclonal Antibody
Application:
IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Price
Catalog Number
$460
LS-A13632-50

Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
ACE2 / ACE-2 Rabbit anti-Human Polyclonal Antibody
Application:
IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified

Specifications

Description
Angiotensin-Converting Enzyme 2 (ACE2) is a transmembrane protein found in the lungs, intestines, heart, kidney, liver and arteries that plays a central role in vascular, renal, and myocardial physiology. The normal function of ACE2 is to convert the inactive vasoconstrictor angiotensin I (AngI) to Ang1-9 and the active form AngII to Ang1-7. It is involved in controlling vascular function including blood pressure, and absence of ACE2 expression in ace2-/ace2- mice leads to severely reduced cardiac contractility, indicating its importance in regulating heart function. ACE2 is also the primary attachment receptor for HCoV-N63, SARS-CoV and SARS-CoV-2. The S1 portion of the coronavirus spike protein attaches to ACE2 presented on the host cell surface. The SARS-CoV-2 virus targets pneumocytes and macrophages expressing ACE2 in the lung, and it is believed to infect ACE2-positive cells in other tissues including the gastrointestinal tract and potentially the liver (in cholangiocytes). Hoffmann et al., 2020, Cell. 181, 1–10. April 16, 2020, DOI: 10.1016/j.cell.2020.02.052; Zhou, P et al. Nature.579, 270–273 (2020). DOI: 10.1038/s41586-020-2012-7; Xiaoqiang Chai et al. bioRxiv 2020.02.03.931766, DOI: 10.1101/2020.02.03.931766; Tikellis, Chris, and M C Thomas. Int J Pep. vol. 2012 (2012): 256294. doi:10.1155/2012/256294; Wrap et al. Science, 13 Mar 2020:Vol. 367, Issue 6483, pp. 1260-1263. DOI: 10.1126/science.abb2507;
Target
Human ACE2 / ACE-2
Synonyms
ACE2 | ACE-related carboxypeptidase | ACEH | Metalloprotease MPROT15 | SARS-CoV2 Coronavirus Receptor | SARS-CoV-2 Coronavirus Receptor | COVID-19 viral receptor
Host
Rabbit
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
LP-13632, synthetic peptide
Applications
  • IHC - Paraffin (10 µg/ml)
  • Western blot (1:1000)
  • ELISA (1:100)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, 0.1% Sodium Azide
Storage
Aliquot and store undiluted at -20°C or below for up to 1 year. Can be stored undiluted at 4°C for up to 1 month. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About ACE2 / ACE-2
Q9BYF1 NM_021804 NP_068576.1

Validation

ACE2 / ACE-2 Antibody - Human Testis: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Testis: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Testis: Formalin-Fixed, Paraffin-Embedded (FFPE)

ACE2 / ACE-2 Antibody - Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)

ACE2 / ACE-2 Antibody - Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)

ACE2 / ACE-2 Antibody - Western Blot: LS-A13632 (1:100) vs. full-length recombinant human ACE2 protein. Lane 7: 50 ng, Lane 8: 100 ng, Lane 9 500ng. Detection fluorescent conjugated anti-rabbit secondary antibody (1:100).
Western Blot: LS-A13632 (1:100) vs. full-length recombinant human ACE2 protein. Lane 7: 50 ng, Lane 8: 100 ng, Lane 9 500ng. Detection fluorescent conjugated anti-rabbit secondary antibody (1:100).
Western Blot: LS-A13632 (1:100) vs. full-length recombinant human ACE2 protein. Lane 7: 50 ng, Lane 8: 100 ng, Lane 9 500ng. Detection fluorescent conjugated anti-rabbit secondary antibody (1:100).

ACE2 / ACE-2 Antibody - Indirect detection ELISA against full length Recombinant Human ACE2. Primary antibody LS-13632 was diluted 1:100 (10ug/mL final concentration). Secondary goat anti-rabbit HRP conjugated antibody was diluted 1:100.
Indirect detection ELISA against full length Recombinant Human ACE2. Primary antibody LS-13632 was diluted 1:100 (10ug/mL final concentration). Secondary goat anti-rabbit HRP conjugated antibody was diluted 1:100.
Indirect detection ELISA against full length Recombinant Human ACE2. Primary antibody LS-13632 was diluted 1:100 (10ug/mL final concentration). Secondary goat anti-rabbit HRP conjugated antibody was diluted 1:100.

ACE2 / ACE-2 Antibody - Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control).  Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Electropherogram)
Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control). Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Electropherogram)
Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control). Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Electropherogram)

ACE2 / ACE-2 Antibody - Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control).  Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Virtual Blot)
Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control). Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Virtual Blot)
Capillary Western Analysis of anti-ACE2 antibody (LS-A13632, 20 µg/mL) using 12-230 kDa separation module. Lane 1: no sample negative control; Lane 2: 1.875µg whole human kidney lysate (positive control), Lane 3: 1.875µg whole human brain lysate (negative control). Antibody produced a predominant ~63kDa and minor ~58kDa band in the kidney, and no banding in the brain. (Protein Simple Virtual Blot)

LSBio Ratings

PathPlus™ ACE2 / ACE-2 Antibody for IHC, WB/Western, ELISA LS-A13632 has an LSBio Rating of
Laboratory Validation Score (5)

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/21/2024